Entrepreneurship

Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the biotechnology ecosystem in the region.

UVA researchers propose that the business community can address sustainability challenges through innovation and development of new technologies.

UVA awarded $3.5 million to UVA-Wise to create an innovation ecosystem in the region. Funding will establish a Center for Innovation and boost enrollment in computer science and software engineering programs at the college.

UVA researchers propose that the business community can address sustainability challenges through innovation and development of new technologies.